Medivation Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Northwest Biotherapeutics.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Founding Date
Founding Date
2000
Founding Date
1998
Type
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Bethesda, US HQ
Employees
Employees
82517% decrease
Employees
1721% increase
Valuation ($)
Valuation ($)
648.3 m
Valuation ($)
349.5 m

Financial

Revenue (est.)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
$1.4m (FY, 2025)
Net income
Net income
€162.2m (FY, 2024)
Net income
($60.2m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 1.1b
Total funding raised
$ 135.9m
For sources of this data, please see the company profile

View Company Profiles

Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company